Not less but different: Psychotropic drug utilization trends in Norwegian nursing homes during a 12-year period. The Bergen District Nursing Home (BEDNURS) Study

Aging Clinical and Experimental Research

Volumn 16, Issue 4, 2004, Pages 277-282

  Nygaard, Harald A ^a   Ruths, Sabine ^a   Straand, Jørund ^b   Naik, Mala ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Antidepressants; Antipsychotics; Anxiolytics; Cognitive impairment; Hypnotics; Nursing home; Psychotropic drug use

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; SHORT ACTING DRUG; TRICYCLIC ANTIDEPRESSANT AGENT;

AGED; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DRUG USE; FEMALE; GERIATRIC CARE; GERONTOPSYCHIATRY; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MENTAL CAPACITY; MENTAL DISEASE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NORWAY; NURSING HOME; PREDICTION; RATING SCALE; RESIDENTIAL CARE; SENILE DEMENTIA;

EID: 8644247658     PISSN: 15940667     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03324552     Document Type: Article

References (33)

1. Beardsley RS, Larson DB, Burns BJ, Thompson JW, Kamerow DB. Prescribing of psychotropics in elderly nursing home patients. J Am Geriatr Soc 1989; 37: 327-30.
2. Beers MH, Ouslander JG, Fingold SF, et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992; 117: 684-9.
3. Nygaard HA, Bakke K, Breivik K, Brudvik E. Mental and physical capacity and consumption of neuroleptic drugs in residents of nursing homes. Int J Geriatr Psychiatry 1990; 5: 303-8.
4. Sørensen L, Foldspang A, Gulmann N, Munk-Jørgensen P. Determinants for the use of psychotropics among nursing home residents. Int J Geriatr Psychiatry 2001; 16: 147-54.
5. Draper B, Brodaty H, Low L-F, et al. Use of psychotropics in Sydney nursing homes: association with depression, psychosis, and behavioral disturbances. Int Psychogeriatr 2001; 13: 107-20.
6. Wancata J, Benda N, Hajji M, Lesch O. Prevalence and course of psychiatric disorders among nursing home admissions. Soc Psychiatry Psychiatr Epidemiol 1998; 33: 74-9.
7. Wancata J, Benda N, Meise U, Müller C. Psychotropic drug intake in residents newly admitted to nursing homes. Psychopharmacology 1997; 134: 115-20.
8. Avorn J, Soumerai SB, Everitt DE, et al. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med 1992; 327: 168-73.
9. Furniss L, Burns A, Craig S, Scobie S, Cooke J, Faragher B. Effects of a pharmacist's medication review in nursing homes. Br J Psychiatry 2000; 176: 563-7.
10. Stoudemire A, Smith D. OBRA regulations and the use of psychotropic drugs in long-term care facilities. Impact and implications for geropsychiatric care. Gen Hosp Psychiatry 1996; 18: 77-94.
11. Semla TP, Palla K, Poddig B, Brauner DJ. Effect of the Omnibus Reconciliation Act 1987 on antipsychotic prescribing in nursing home residents. J Am Geriatr Soc 1994; 42: 648-52.
12. Borson S, Doane K. The impact of OBRA-87 on psychotropic drug prescribing in skilled nursing facilities. Psychiat Serv 1997; 48: 1289-96.
13. Llorente MD, Olsen EJ, Leyva O, Silverman MA, Lewis JE, Rivero J. Use of antipsychotic drugs in nursing homes: current compliance with OBRA regulations. J Am Geriatr Soc 1998; 46: 198-201.
14. Medical Products Agency and The Norwegian Medical Control Authority. Treatment of mental conditions in patients with dementia. Workshop. 1994. Uppsala, 1995.
15. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for staging of dementia. Br J Psychiatry 1982; 140: 566-72.
16. Adolfsson R, Gottfries CG, Nyström L, Winblad B. Prevalence of dementia disorders in institutionalized Swedish old people. The work load imposed by caring for these patients. Acta Psychiatr Scand 1981; 63: 225-44.
17. World Health Organization. Anatomical Therapeutical Chemical (ATC) classification index including defined daily doses (DDD) for plain substances. Oslo: World Health Organization Collaborating Center for Drug Statistics Methodology, 1997.
18. Nygaard HA, Ruths S. Missing the diagnosis: senile dementia in patients admitted to nursing homes. Scand J Prim Health Care 2003; 21: 148-52.
19. Skoog I, Nilsson L, Landahl S, Steen B. Mental disorders and the use of psychotropic drugs in an 85-year-old urban population. Int Psychogeriatr 1993; 5: 33-48.
20. Nygaard HA, Brudvik E, Juvik OB, Pedersen WE, Rotevatn TS, Vollset Å. Consumption of psychotropic drugs in nursing home residents: a prospective study in patients permanently admitted to a nursing home. Int J Geriatr Psychiatry 1994; 9: 387-91.
21. Conn D, Ferguson I, Mandelman K, Ward C. Psychotropic drug utilization in long-term care facilities for the elderly in Ontario, Canada. Int Psychogeriatr 1999; 11: 223-33.
22. Schmidt I, Claesson C, Westerholm B, Nilsson L, Svarstad B. The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. J Am Geriatr Soc 1998; 46: 77-82.
23. Giron M, Forsell Y, Bernsten C, Thorslund M, Winblad B, Fastbom J. Psychotropic drug use in elderly people with and without dementia. Int J Geriatr Psychiatry 2001; 16: 900-6.
24. Schmidt I, Fastbom J. Quality of drug use in Swedish nursing homes. A follow-up study. Clin Drug Invest 2000; 20: 433-46.
25. Arthur A, Matthews R, Jagger C, Lindesay J. Factors associated with antidepressant treatment in residential care: changes between 1990 and 1997. Int J Geriatr Psychiatry 2002; 17: 54-60.
26. McGrath A, Jackson G. Survey of neuroleptic prescribing in residents of nursing homes in Glasgow. BMJ 1996; 312: 611-2.
27. van Dijk KN, de Vries CS, van den Berg PB, Brouwers JRBJ, de Jong-van den Berg LTW. Drug utilisation in Dutch nursing homes. Eur J Clin Pharmacol 2000; 55: 765-71.
28. Castle N. Changes in resident and facility risk factors for psychotropic drug use in nursing homes since the Nursing Home Reform Act. J Applied Gerontol 1999; 18: 77-98.
29. Lindesay J, Matthews R, Jagger C. Factors associated with antipsychotic drug use in residential care: changes between 1990 and 1997. Int J Geriatr Psychiatry 2003; 18: 511-9.
30. Macdonald A, Carpenter G, Box O, Roberts A. Dementia and use of psychotropic medication in non-"Elderly Mentally Infirm" nursing homes in South East England. Age Ageing 2002; 31: 58-64.
31. Lasser RA, Sunderland T. Newer psychotropic medication use in nursing home residents. J Am Geriatr Soc 1998; 46: 202-7.
32. Ruths S, Straand J, Nygaard HA. Psychotropic drug use in nursing homes - diagnostic indications and variations between institutions. Eur J Clin Pharmacol 2001; 57: 523-8.
33. Lyketsos CG, Steele C, Galik E, et al. Physical aggression in dementia patients and its relationship to depression. Am J Psychiatry 1999; 156: 66-71.